Earnings call transcript: Trifast lifts margins in H2 2026 as revenue falls

Trifast reported FY 2026 revenue of GBP 207m (-7.3% YoY) but improved profitability, with gross margin up 170bps to 30% and underlying EBIT rising to GBP 16.3m (uEBIT margin +110bps to 7.8%). Balance-sheet strength improved alongside cash generation: net debt fell to GBP 16m and leverage dropped to 0.75x, while underlying operating cash flow reached GBP 21.4m. The company increased its full-year dividend to GBP 0.019/share and reiterated FY 2027 momentum is in line with board expectations, targeting double-digit EBIT margins over the medium term.

Analysis

The market is still pricing Trifast like a cyclical fastener supplier, but the real lever is mix shift plus process control. If management can keep revenue from leaking while standardizing pricing, inventory and cost-to-serve across geographies, the earnings power can re-rate faster than the top line suggests. That is especially true because the business is effectively converting from volume exposure to embedded-supplier economics, where switching costs and engineering support matter more than unit pricing.

Near term, the obvious risk is that investors punish the revenue decline before they credit the margin reset. That makes the next 1-2 prints critical: if H1 FY27 stays flat and H2 conversion slips, the stock likely stays range-bound. But over 6-18 months, the de-risked balance sheet and lower working-capital intensity should give management room to compound EBIT faster than sales, which is usually worth a higher multiple in a sub-scale industrial.

The consensus seems to miss that the turnaround is not just cost cutting; it is a selective exit from lower-return activity, which can mechanically improve ROIC even if absolute revenue is weaker. The contrarian risk is that smart infrastructure and medical look better in slide decks than in backlog conversion, so the thesis depends on real order flow, not pipeline anecdotes. I would watch for evidence that margin gains come from sustainable mix and pricing, not one-offs like inventory clean-up or tariff pass-through.

Key Decisions for Investors

• Long TRFT on pullbacks for a 6-12 month horizon if the stock remains below the upper end of its 52-week range; thesis is margin-led EPS compounding and balance-sheet optionality. Falsifier: H1 FY27 revenue and EBIT margin fail to hold near the company’s indicated run-rate.
• Pair trade: long industrial supply-chain enablers (FAST, GWW) vs short more auto-exposed component suppliers in Europe/UK if available. The mechanism is that embedded service models with pricing power should outperform pure volume names as auto remains soft.
• Do not chase the shares immediately after earnings; wait for a 1-2 month confirmation that new business converts in H2. If conversion is visible, use a starter position and add on evidence of margin stability above the current run-rate.
• Set an alert on EBIT margin progression and working-capital intensity at the next update. If margin expansion is coming from sustainable pricing and procurement rather than inventory releases, the multiple can expand; if not, treat the move as overdone.